David P Carbone

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 38

Top Venues

Nature medicine

Journal of translational medicine

JCO precision oncology

Journal for immunotherapy of cancer

Vanderbilt University School of Medicine

Johns Hopkins University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University School of Medicine Jul 01 1996 - Aug 31 2012

United States

Professor :: Medicine

Education History

Johns Hopkins University

United States

PHD :: Medicine and Molecular Biology/Genetics

Publications

Daniel Morgensztern, Neal E Ready, Melissa Lynne Johnson, Afshin Dowlati, Noura J Choudhury, David P Carbone, Eric Schaefer, Susanne M Arnold, Sonam Puri, Zofia Piotrowska, Aparna Hegde, Anne C Chiang, Wade T Iams, Anthony W Tolcher, Kaname Nosaki, Toshiyuki Kozuki, Tianhong Li, Rafael Santana-Davila, Hiroaki Akamatsu, Haruyasu Murakami, Hiroshi Yokouchi, Song Wang, Jiuhong Zha, Rui Li, Randy R Robinson, Pooja Hingorani, Edwin E Jeng, Muhammad Furqan
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients With Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Amy R Rappaport, Chrisann Kyi, Monica Lane, Meghan G Hart, Melissa Lynne Johnson, Brian S Henick, Chih-Yi Liao, Amit Mahipal, Ardaman Shergill, Alexander I Spira, Jonathan Wade Goldman, Ciaran D Scallan, Desiree Schenk, Christine D Palmer, Matthew J Davis, Sonia Kounlavouth, Lindsey Kemp, Aaron Yang, Yaojun John Li, Molly Likes, Annie Shen, Gregory R Boucher, Milana Egorova, Robert L Veres, J Aaron Espinosa, Jason R Jaroslavsky, Lauren D Kraemer Tardif, Lindsey Acrebuche, Christopher Puccia, Leiliane Sousa, Rita Zhou, Kyounghwa Bae, J Randolph Hecht, David P Carbone, Benny Johnson, Andrew Allen, Andrew R Ferguson, Karin Jooss
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nature medicine 30 (4) (2024)
Amy R Rappaport, Chrisann Kyi, Monica Lane, Meghan G Hart, Melissa Lynne Johnson, Brian S Henick, Chih-Yi Liao, Amit Mahipal, Ardaman Shergill, Alexander I Spira, Jonathan Wade Goldman, Ciaran D Scallan, Desiree Schenk, Christine D Palmer, Matthew J Davis, Sonia Kounlavouth, Lindsey Kemp, Aaron Yang, Yaojun John Li, Molly Likes, Annie Shen, Gregory R Boucher, Milana Egorova, Robert L Veres, J Aaron Espinosa, Jason R Jaroslavsky, Lauren D Kraemer Tardif, Lindsey Acrebuche, Christopher Puccia, Leiliane Sousa, Rita Zhou, Kyounghwa Bae, J Randolph Hecht, David P Carbone, Benny Johnson, Andrew Allen, Andrew R Ferguson, Karin Jooss
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nature medicine 30 (4) (2024)
Amy R Rappaport, Chrisann Kyi, Monica Lane, Meghan G Hart, Melissa Lynne Johnson, Brian S Henick, Chih-Yi Liao, Amit Mahipal, Ardaman Shergill, Alexander I Spira, Jonathan Wade Goldman, Ciaran D Scallan, Desiree Schenk, Christine D Palmer, Matthew J Davis, Sonia Kounlavouth, Lindsey Kemp, Aaron Yang, Yaojun John Li, Molly Likes, Annie Shen, Gregory R Boucher, Milana Egorova, Robert L Veres, J Aaron Espinosa, Jason R Jaroslavsky, Lauren D Kraemer Tardif, Lindsey Acrebuche, Christopher Puccia, Leiliane Sousa, Rita Zhou, Kyounghwa Bae, J Randolph Hecht, David P Carbone, Benny Johnson, Andrew Allen, Andrew R Ferguson, Karin Jooss
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nature medicine 30 (4) (2024)
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I Mäyränpää, Jie Bao, Emmy W Verschuren, Eiman I Ahmed, Michele Ceccarelli, Lance D Miller, Gianni Monaco, Wouter R L Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D Laajala, William J Geese, Justin Guinney, Joseph D Szustakowski, Benjamin G Vincent, David P Carbone
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I Mäyränpää, Jie Bao, Emmy W Verschuren, Eiman I Ahmed, Michele Ceccarelli, Lance D Miller, Gianni Monaco, Wouter R L Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D Laajala, William J Geese, Justin Guinney, Joseph D Szustakowski, Benjamin G Vincent, David P Carbone
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Amy R Rappaport, Chrisann Kyi, Monica Lane, Meghan G Hart, Melissa Lynne Johnson, Brian S Henick, Chih-Yi Liao, Amit Mahipal, Ardaman Shergill, Alexander I Spira, Jonathan Wade Goldman, Ciaran D Scallan, Desiree Schenk, Christine D Palmer, Matthew J Davis, Sonia Kounlavouth, Lindsey Kemp, Aaron Yang, Yaojun John Li, Molly Likes, Annie Shen, Gregory R Boucher, Milana Egorova, Robert L Veres, J Aaron Espinosa, Jason R Jaroslavsky, Lauren D Kraemer Tardif, Lindsey Acrebuche, Christopher Puccia, Leiliane Sousa, Rita Zhou, Kyounghwa Bae, J Randolph Hecht, David P Carbone, Benny Johnson, Andrew Allen, Andrew R Ferguson, Karin Jooss
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nature medicine 30 (4) (2024)
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I Mäyränpää, Jie Bao, Emmy W Verschuren, Eiman I Ahmed, Michele Ceccarelli, Lance D Miller, Gianni Monaco, Wouter R L Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D Laajala, William J Geese, Justin Guinney, Joseph D Szustakowski, Benjamin G Vincent, David P Carbone
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I Mäyränpää, Jie Bao, Emmy W Verschuren, Eiman I Ahmed, Michele Ceccarelli, Lance D Miller, Gianni Monaco, Wouter R L Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D Laajala, William J Geese, Justin Guinney, Joseph D Szustakowski, Benjamin G Vincent, David P Carbone
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I Mäyränpää, Jie Bao, Emmy W Verschuren, Eiman I Ahmed, Michele Ceccarelli, Lance D Miller, Gianni Monaco, Wouter R L Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D Laajala, William J Geese, Justin Guinney, Joseph D Szustakowski, Benjamin G Vincent, David P Carbone
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
David P Carbone, Tudor-Eliade Ciuleanu, Michael Schenker, Manuel Cobo, Stéphanie Bordenave, Oscar Juan-Vidal, Juliana Menezes, Niels Reinmuth, Eduardo Richardet, Ying Cheng, Hideaki Mizutani, Enriqueta Felip, Bogdan Zurawski, Aurelia Alexandru, Luis Paz-Ares, Shun Lu, Thomas John, Xiaoqing Zhang, Javed Mahmood, Nan Hu, Tuli De, Irene Santi, John R Penrod, Yong Yuan, Adam Lee, Martin Reck
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial. Journal for immunotherapy of cancer 12 (2) (2024)
Amy R Rappaport, Chrisann Kyi, Monica Lane, Meghan G Hart, Melissa Lynne Johnson, Brian S Henick, Chih-Yi Liao, Amit Mahipal, Ardaman Shergill, Alexander I Spira, Jonathan Wade Goldman, Ciaran D Scallan, Desiree Schenk, Christine D Palmer, Matthew J Davis, Sonia Kounlavouth, Lindsey Kemp, Aaron Yang, Yaojun John Li, Molly Likes, Annie Shen, Gregory R Boucher, Milana Egorova, Robert L Veres, J Aaron Espinosa, Jason R Jaroslavsky, Lauren D Kraemer Tardif, Lindsey Acrebuche, Christopher Puccia, Leiliane Sousa, Rita Zhou, Kyounghwa Bae, J Randolph Hecht, David P Carbone, Benny Johnson, Andrew Allen, Andrew R Ferguson, Karin Jooss
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nature medicine (2024)
David P Carbone, Tudor-Eliade Ciuleanu, Michael Schenker, Manuel Cobo, Stéphanie Bordenave, Oscar Juan-Vidal, Juliana Menezes, Niels Reinmuth, Eduardo Richardet, Ying Cheng, Hideaki Mizutani, Enriqueta Felip, Bogdan Zurawski, Aurelia Alexandru, Luis Paz-Ares, Shun Lu, Thomas John, Xiaoqing Zhang, Javed Mahmood, Nan Hu, Tuli De, Irene Santi, John R Penrod, Yong Yuan, Adam Lee, Martin Reck
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial. Journal for immunotherapy of cancer 12 (2) (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
David P Carbone, Tudor-Eliade Ciuleanu, Michael Schenker, Manuel Cobo, Stéphanie Bordenave, Oscar Juan-Vidal, Juliana Menezes, Niels Reinmuth, Eduardo Richardet, Ying Cheng, Hideaki Mizutani, Enriqueta Felip, Bogdan Zurawski, Aurelia Alexandru, Luis Paz-Ares, Shun Lu, Thomas John, Xiaoqing Zhang, Javed Mahmood, Nan Hu, Tuli De, Irene Santi, John R Penrod, Yong Yuan, Adam Lee, Martin Reck
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial. Journal for immunotherapy of cancer 12 (2) (2024)
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I Mäyränpää, Jie Bao, Emmy W Verschuren, Eiman I Ahmed, Michele Ceccarelli, Lance D Miller, Gianni Monaco, Wouter R L Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D Laajala, William J Geese, Justin Guinney, Joseph D Szustakowski, Benjamin G Vincent, David P Carbone
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I Mäyränpää, Jie Bao, Emmy W Verschuren, Eiman I Ahmed, Michele Ceccarelli, Lance D Miller, Gianni Monaco, Wouter R L Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D Laajala, William J Geese, Justin Guinney, Joseph D Szustakowski, Benjamin G Vincent, David P Carbone
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Amy R Rappaport, Chrisann Kyi, Monica Lane, Meghan G Hart, Melissa Lynne Johnson, Brian S Henick, Chih-Yi Liao, Amit Mahipal, Ardaman Shergill, Alexander I Spira, Jonathan Wade Goldman, Ciaran D Scallan, Desiree Schenk, Christine D Palmer, Matthew J Davis, Sonia Kounlavouth, Lindsey Kemp, Aaron Yang, Yaojun John Li, Molly Likes, Annie Shen, Gregory R Boucher, Milana Egorova, Robert L Veres, J Aaron Espinosa, Jason R Jaroslavsky, Lauren D Kraemer Tardif, Lindsey Acrebuche, Christopher Puccia, Leiliane Sousa, Rita Zhou, Kyounghwa Bae, J Randolph Hecht, David P Carbone, Benny Johnson, Andrew Allen, Andrew R Ferguson, Karin Jooss
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nature medicine 30 (4) (2024)
Mike Mason, Óscar Lapuente-Santana, Anni S Halkola, Wenyu Wang, Raghvendra Mall, Xu Xiao, Jacob Kaufman, Jingxin Fu, Jacob Pfeil, Jineta Banerjee, Verena Chung, Han Chang, Scott D Chasalow, Hung Ying Lin, Rongrong Chai, Thomas Yu, Francesca Finotello, Tuomas Mirtti, Mikko I Mäyränpää, Jie Bao, Emmy W Verschuren, Eiman I Ahmed, Michele Ceccarelli, Lance D Miller, Gianni Monaco, Wouter R L Hendrickx, Shimaa Sherif, Lin Yang, Ming Tang, Shengqing Stan Gu, Wubing Zhang, Yi Zhang, Zexian Zeng, Avinash Das Sahu, Yang Liu, Wenxian Yang, Davide Bedognetti, Jing Tang, Federica Eduati, Teemu D Laajala, William J Geese, Justin Guinney, Joseph D Szustakowski, Benjamin G Vincent, David P Carbone
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Geoffrey R Oxnard, Ruthia Chen, Jennifer C Pharr, Diane R Koeller, Arrien A Bertram, Suzanne E Dahlberg, Irene R Rainville, Kate P Shane-Carson, Kelly A Taylor, Alicia Sable-Hunt, Lynette M Sholl, Craig C Teerlink, Alun Thomas, Lisa Anne Cannon-Albright, André P Fay, Patricia Ashton-Prolla, Hao Yang, Mary M Salvatore, Bonnie J Addario, Pasi A Janne, David P Carbone, Georgia L Wiesner, Judy E Garber
Germline EGFR mutations and familial lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rebecca Hoyd, Caroline E Dravillas, YunZhou Liu, Malvenderjit S Jagjit Singh, Mitchell Muniak, Ning Jin, Nicholas C Denko, David P Carbone, Xiaokui M Mo, Daniel J Spakowicz
Exogenous sequences in tumors and immune cells (exotic): a tool for estimating the microbe abundances in tumor RNAseq data. Cancer research communications (2023)
Jamie E Chaft, Filiz Oezkan, Mark G Kris, Paul A Bunn, Ignacio I Wistuba, David J Kwiatkowski, Dwight H Owen, Yan Tang, Bruce E Johnson, Jay M Lee, Gerard Lozanski, Maciej Pietrzak, Michal Seweryn, Woo Yul Byun, Katja Schulze, Alan Nicholas, Ann Johnson, Jessica Grindheim, Stephanie Hilz, David S Shames, Chris Rivard, Eric Toloza, Eric B Haura, Ciaran J McNamee, G Alexander Patterson, Saiama N Waqar, Valerie W Rusch, David P Carbone, null null
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nature medicine (2023)
Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh, Vollter Anastas, Keith A Nair, Arturo Orlacchio, Vasiliki Taraslia, Ioannis Vlachos, Marina Capece, Artemis Hatzigeorgiou, Dario Palmieri, Christos Tsatsanis, Salvatore Alaimo, Lalit Sehgal, David P Carbone, Vincenzo Coppola, Philip N Tsichlis
Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing. Nature communications 13 (1) (2022)
Jamie E Chaft, Filiz Oezkan, Mark G Kris, Paul A Bunn, Ignacio I Wistuba, David J Kwiatkowski, Dwight H Owen, Yan Tang, Bruce E Johnson, Jay M Lee, Gerard Lozanski, Maciej Pietrzak, Michal Seweryn, Woo Yul Byun, Katja Schulze, Alan Nicholas, Ann Johnson, Jessica Grindheim, Stephanie Hilz, David S Shames, Chris Rivard, Eric Toloza, Eric B Haura, Ciaran J McNamee, G Alexander Patterson, Saiama N Waqar, Valerie W Rusch, David P Carbone, null null
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nature medicine 28 (10) (2022)
Luiz Henrique Araujo, Vladmir C Cordeiro de Lima, David P Carbone
Genetic Ancestry Affects Somatic Alterations in Lung Cancers. Cancer discovery 11 (6) (2022)
Christine D Palmer, Amy R Rappaport, Matthew J Davis, Meghan G Hart, Ciaran D Scallan, Sue-Jean Hong, Leonid Gitlin, Lauren D Kraemer, Sonia Kounlavouth, Aaron Yang, Lindsey Smith, Desiree Schenk, Mojca Skoberne, Kiara Taquechel, Martina Marrali, Jason R Jaroslavsky, Charmaine N Nganje, Elizabeth Maloney, Rita Zhou, Daniel Navarro-Gomez, Adrienne C Greene, Gijsbert Grotenbreg, Renee Greer, Wade Blair, Minh Duc Cao, Shawn Chan, Kyounghwa Bae, Alexander I Spira, Sameek Roychowdhury, David P Carbone, Brian S Henick, Charles G Drake, Benjamin J Solomon, Daniel H Ahn, Amit Mahipal, Steven B Maron, Benny Johnson, Raphael Rousseau, Katrine L Whiteson, Chih-Yi Liao, Daniel V T Catenacci, Andrew Allen, Andrew R Ferguson, Karin Jooss
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results. Nature medicine 28 (8) (2022)
Thomas R Valentine, Carolyn J Presley, David P Carbone, Peter G Shields, Barbara L Andersen
Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancer. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 41 (6) (2022)
Xinyu Zhang, Zhuo Yu, Yaping Xu, Yencheng Chao, Qin Hu, Chun Li, Maosong Ye, Xiuli Zhu, Liang Cui, Jing Bai, Yuhua Gong, Yanfang Guan, Min Zhou, Jian'an Huang, Hua Zhang, Tao Ren, Qian Shen, Kai Wang, Yingyong Hou, Xuefeng Xia, Xingxiang Pu, David P Carbone, Xin Zhang
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules. British journal of cancer 127 (12) (2022)
Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh, Vollter Anastas, Keith A Nair, Arturo Orlacchio, Vasiliki Taraslia, Ioannis Vlachos, Marina Capece, Artemis Hatzigeorgiou, Dario Palmieri, Christos Tsatsanis, Salvatore Alaimo, Lalit Sehgal, David P Carbone, Vincenzo Coppola, Philip N Tsichlis
AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing. Nature communications 12 (1) (2021)
Walter Z Wang, Konstantin Shilo, Joseph M Amann, Alyssa Shulman, Mohammad Hojjat-Farsangi, Håkan Mellstedt, Johan Schultz, Carlo M Croce, David P Carbone
Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung. Cell death & disease 12 (6) (2021)
Jiefei Han, Ruofei Yu, Jianchun Duan, Jin Li, Wei Zhao, Guoshuang Feng, Hua Bai, Yu-Qi Wang, Xue Zhang, Rui Wan, Jiachen Xu, Xin Wang, Yanfang Guan, Xuefeng Xia, Zhuoran Yao, Kailun Fei, David P Carbone, Zhijie Wang, Jie Wang
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers. Science advances 7 (21) (2021)
Alessandra Metelli, Bill X Wu, Brian Riesenberg, Silvia Guglietta, John D Huck, Catherine M Mills, Anqi Li, Saleh Rachidi, Carsten Krieg, Mark P Rubinstein, Daniel T Gewirth, Shaoli Sun, Michael B Lilly, Amy H Wahlquist, David P Carbone, Yiping Yang, Bei Liu, Zihai Li
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β. Science translational medicine 12 (525) (2021)
Michael J Koenig, Bernice A Agana, Jacob M Kaufman, Michael F Sharpnack, Walter Z Wang, Christoph Weigel, Fábio C P Navarro, Joseph M Amann, Nicole Cacciato, Rajeswara Rao Arasada, Mark B Gerstein, Vicki H Wysocki, Christopher Oakes, David P Carbone
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma. Cancer research 81 (16) (2021)
Ferdinando Cerciello, Meena Choi, Sara L Sinicropi-Yao, Katie Lomeo, Joseph M Amann, Emanuela Felley-Bosco, Rolf A Stahel, Bruce W S Robinson, Jenette Creaney, Harvey I Pass, Olga Vitek, David P Carbone
Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (10) (2020)
Walter Z Wang, David P Carbone, Rajeswara Rao Arasada
Novel mechanism of resistance to targeted therapies in lung cancer. Molecular & cellular oncology 6 (1) (2018)

David P Carbone.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David P Carbone